‘Hands Off Our NHS’: Anti-Palantir Protests Break Out in UK Over Deal With National Health Service
Protesters in Manchester challenged Palantir’s NHS contract, citing privacy, security, and political concerns. The UK government is reviewing the deal.
Intelligence analysis by GPT-5.4 Mini
Around 80 protesters gathered outside an NHS conference in Manchester to oppose Palantir’s role in the UK health service. The dispute centers on a contract that gives Palantir access to NHS data tools and has triggered wider questions about privacy, national security, and dependence on a US vendor.
A big group of people is upset that the NHS is using a US company’s tools to help manage health data. They worry it is like giving someone else the keys to a giant hospital filing cabinet.
Analysis
What happened
Protesters in hospital gowns gathered outside the NHS ConfedExpo in Manchester to oppose the UK National Health Service’s deal with Palantir. They carried signs like “Patients vs. Palantir” and chanted against what they saw as outside control over health data.
Why the deal is controversial
The contract is reportedly worth up to $440 million and runs through 2031, though it includes a break clause that could let the government exit next February. It gives Palantir access to data analytics and AI services for a federated data platform meant to help reduce wait times and cut waste. Critics argue that a foreign company should not be handling sensitive health information, especially given Palantir’s work with US immigration authorities and the Israeli military, which some protesters also objected to.
The article says the relationship has faced growing scrutiny. In 2023, Palantir cofounder Peter Thiel’s comments about the NHS, along with a manifesto tied to CEO Alex Karp’s book, added to political concerns. Palantir has denied being aligned with any one ideology, and the company says it is not politically monolithic.
The policy fight is widening
The story also notes that MPs recently warned Palantir’s growing role in the UK public sector could create an “unacceptable point of weakness.” After that report, UK technology secretary Liz Kendall said the government was reviewing every part of the NHS contract before deciding whether to continue it. Supporters of the platform, including an NHS data executive quoted in the piece, say it helps patients and saves money. But one NHS area in Greater Manchester has already declined to use it, saying its own software performs better.
The result is a broader fight over whether the state should build core data systems in-house or rely on a powerful outside vendor.
Key points
- Protesters in Manchester opposed Palantir’s NHS deal over privacy, security, and political concerns.
- The contract is said to be worth up to $440 million and could run until 2031, with an exit option next February.
- Palantir’s role in UK public-sector data systems has drawn scrutiny from MPs and government officials.
- Supporters say the platform can help patients and reduce costs, while some NHS teams prefer their own software.
If the review leads to clearer limits and stronger oversight, the NHS could keep useful software tools while reducing trust and privacy concerns. The platform could still help lower wait times and save money if it proves effective in practice.
If public trust keeps falling, the contract could become a long-running political fight and make future data projects harder to roll out. The NHS could also end up tied to a system some trusts do not want to use, limiting adoption and increasing dependence on one vendor.
